{"id":"https://openalex.org/W4406541501","doi":"https://doi.org/10.1158/1078-0432.28227551","title":"Supplementary Table S1 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer","display_name":"Supplementary Table S1 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer","publication_year":2025,"publication_date":"2025-01-17","ids":{"openalex":"https://openalex.org/W4406541501","doi":"https://doi.org/10.1158/1078-0432.28227551"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.28227551","doi":"https://doi.org/10.1158/1078-0432.28227551","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28227551","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.28227551","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5073289880","display_name":"Randy F. Sweis","orcid":"https://orcid.org/0000-0002-0497-9637","observed_orcids":["https://orcid.org/0000-0002-0497-9637"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Randy F. Sweis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0497-9637","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089256383","display_name":"Gurkamal S. Chatta","orcid":"https://orcid.org/0000-0002-3154-9042","observed_orcids":["https://orcid.org/0000-0002-3154-9042"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gurkamal S. Chatta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3154-9042","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152191","display_name":"Rohit Jain","orcid":"https://orcid.org/0000-0002-9295-9360","observed_orcids":["https://orcid.org/0000-0002-9295-9360"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rohit K. Jain","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9295-9360","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112689275","display_name":"Helen Moon","orcid":"https://orcid.org/0009-0007-6303-5285","observed_orcids":["https://orcid.org/0009-0007-6303-5285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Moon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0007-6303-5285","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091597858","display_name":"Scott Edward Delacroix","orcid":"https://orcid.org/0000-0001-8291-409X","observed_orcids":["https://orcid.org/0000-0001-8291-409X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Scott Edward Delacroix","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8291-409X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104236137","display_name":"Alana Fang","orcid":"https://orcid.org/0009-0000-7993-7370","observed_orcids":["https://orcid.org/0009-0000-7993-7370"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alana Fang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-7993-7370","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001217103","display_name":"Leonard D\u2019Amico","orcid":"https://orcid.org/0000-0002-1143-7297","observed_orcids":["https://orcid.org/0000-0002-1143-7297"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonard D\u2019Amico","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1143-7297","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002960913","display_name":"Angela Shaulov Kask","orcid":"https://orcid.org/0009-0001-4175-7339","observed_orcids":["https://orcid.org/0009-0001-4175-7339"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Shaulov Kask","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0001-4175-7339","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007551071","display_name":"Martin A. Cheever","orcid":"https://orcid.org/0000-0002-6892-4141","observed_orcids":["https://orcid.org/0000-0002-6892-4141"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin A. Cheever","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023766816","display_name":"Steven P. Fling","orcid":"https://orcid.org/0000-0001-6263-0153","observed_orcids":["https://orcid.org/0000-0001-6263-0153"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Fling","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6263-0153","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022594161","display_name":"Elad Sharon","orcid":"https://orcid.org/0000-0002-0044-9719","observed_orcids":["https://orcid.org/0000-0002-0044-9719"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elad Sharon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0044-9719","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104236620","display_name":"Andreanne M. Lacroix","orcid":"https://orcid.org/0009-0005-5358-8922","observed_orcids":["https://orcid.org/0009-0005-5358-8922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreanne Lacroix","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5358-8922","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008592962","display_name":"Judith C. Kaiser","orcid":"https://orcid.org/0000-0001-7165-7200","observed_orcids":["https://orcid.org/0000-0001-7165-7200"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judith C. Kaiser","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7165-7200","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083027775","display_name":"Russell Kent Pachynski","orcid":"https://orcid.org/0000-0002-8966-7631","observed_orcids":["https://orcid.org/0000-0002-8966-7631"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Russell K. Pachynski","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8966-7631","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5084909001","display_name":"Evan Y. Yu","orcid":"https://orcid.org/0000-0002-1510-8044","observed_orcids":["https://orcid.org/0000-0002-1510-8044"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Evan Y. Yu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1510-8044","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11232","display_name":"Urinary Tract Infections Management","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9810000061988831},{"id":"https://openalex.org/keywords/interleukin-7","display_name":"IL-7","score":0.9210000038146973},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8420000076293945},{"id":"https://openalex.org/keywords/advanced-bladder-cancer","display_name":"advanced bladder cancer","score":0.753000020980835},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6800000071525574},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.5490000247955322},{"id":"https://openalex.org/keywords/participant-representativeness","display_name":"study participant representativeness","score":0.7260000109672546}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.9611722230911255},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.5765591859817505},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.5751096606254578},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.5594879388809204},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5552809834480286},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48997727036476135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43332356214523315},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3344268202781677},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.27593860030174255},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.22907596826553345},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1892850697040558},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.17610743641853333},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.12493351101875305},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.09993863105773926},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.07463940978050232},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.28227551","doi":"https://doi.org/10.1158/1078-0432.28227551","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28227551","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/28227551","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_A_Phase_II_Open-Label_Randomized_Clinical_Trial_of_Atezolizumab_with_or_without_Human_Recombinant_IL-7_CYT107_in_Advanced_Urothelial_Cancer/28227551","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.28227551","doi":"https://doi.org/10.1158/1078-0432.28227551","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.28227551","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404637161","https://openalex.org/W4406557518","https://openalex.org/W4391333739","https://openalex.org/W4387807097","https://openalex.org/W2947969348","https://openalex.org/W6945856506","https://openalex.org/W4379013973","https://openalex.org/W6941046002","https://openalex.org/W2289712604","https://openalex.org/W7081993533"],"abstract_inverted_index":{"Representativeness":[0],"of":[1],"Study":[2],"Participants":[3]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-01-18T00:00:00"}